Mike led a project with the U.S. Department of Health and Human Services (HHS) Region VIII to bring together regional stakeholders and leaders in the field of adult immunization to help HHS meet the adult immunization goals outlined in its Healthy People 2020 Initiative. The group developed a tool kit of techniques aimed at helping health providers and public health agencies significantly increase adult vaccination rates. (2012)
Mike and a team led a meeting of agency and community leaders to plan for the possibility of a severe pandemic influenza. The meeting helped more than one hundred partners to allocate roles and responsibilities and advance shared plans for their response to a pandemic. (2011)
A fourteen-member team designed and delivered a national public engagement project for CDC to help the agency develop guidance for local, state, federal and private health organizations as they decided how to meet the challenge of the H1N1 virus in the fall and winter flu season of 2009/10. In only sixteen weeks, the team managed ten public meetings, two web engagements and one stakeholder meeting that brought more than 2000 members of the public and representatives of key stakeholders into dialogue with CDC staff and one another in the summer of 2009. Mike served as the project lead.
In 2006, Mike designed and conducted a national public engagement effort to help senior leadership in the agency align their budget with the nation’s most important public health problems. Mike served as the project manager for a team that led public meetings in Washington, D.C.; Little Rock, Arkansas; Oakland, California; San Antonio, Texas; and Boston, Massachusetts with a national tribal meeting in Denver, Colorado. (2006)
Mike worked with the council of leaders from across the organization to identify and address priority health needs within the communities served by the system, establish measures of health improvement, and develop programs to improve diet, exercise, and emotional wellbeing and reduce tobacco use. (2012)
Mike led the work of the Science and Research Work Group of EPA’s Federal Advisory Committee on Children’s Health. He assisted the work group as its members initiated a new research project to link children’s disease and environmental causes at specific life stages. (2000-2001)
Mike engaged the community stakeholders and the Colorado Department of Public Health and Environment in a planning process that will produce the 2014 statewide HIV prevention and care plan (2013-2014)
Mike convened and lead a forum that brings together members of the Huerfano County community and representatives from Shell to discuss oil and natural gas exploration in the county. The forum is aimed at building relationships, deepening communication and developing common understanding of the engineering, environmental, health and economic issues raised by resource extraction.
Mike assisted more than 100 stakeholders to reach consensus on priorities for allocating funding from the Ryan White Care Act and to develop three funding scenarios. This groundbreaking project was the subject of two published accounts of the work it took to build the consensus agreement.
Mike facilitated the work of a technical study group charged with reviewing scientific information about the risks and benefits of fluoridating drinking water supplies and reporting those findings to the Board of Health and Water Board so that they might make recommendations to the City Council concerning the practice of adding fluoride to community drinking water supplies. The Technical Study Group produced a consensus report and, despite conflicting recommendations from the Health Board and the Water Board, the City Council was able to resolve the question and will continue fluoridation.
Justin worked with the Center for Collaborative Policy to provide support to the California Department of Consumer Affairs and the California Department of Public Health as they worked to develop regulations for the medical cannabis industry. He facilitated special interest breakout group sessions in meetings statewide, and assisted with meeting logistics planning.
Mike served as a convener and mediator for six separate ozone reduction efforts.
He identified potential stakeholders, drafted operating protocols, facilitated negotiating sessions, coordinated with DEP personnel, integrated technical presentations, conducted public meetings and mentored in-house DEP facilitators. All of the six processes resulted in specific ozone reduction recommendations designed to assist the Commonwealth meet its obligations under the Clean Air Act. Agency evaluation showed that the Commonwealth significantly improved air quality by reducing the frequency, severity, persistence and spatial extent of high ozone episodes. (1996-2001)
In the summer of 2011, Mike and a team of fourteen helped Harris
County conduct eight public meetings and a meeting with community-based organizations to consider carefully the allocation of resources – vaccines, ventilators and antiviral medication – that would likely be scarce in a severe pandemic. The public meetings drew in nearly 800 community members. Leaders in the Harris County Public Health and Environmental Services Department used the output to finalize a draft plan for pandemic preparedness. Start-to-finish, the project took thirteen weeks.
At the height of the controversy over Dr. Kevorkian’s effort to legalize assisted suicide, Mike initiated, convened and co-facilitated two state-level dialogues on end-of-life issues, including physician-assisted suicide, one in Colorado and a second in California. Participants included religious leaders, health care providers, medical ethicists, right-to-die advocates, pro-life advocates, hospice care providers, government officials and individuals facing end-of-life decisions. The dialogues produced joint statements on improving end-of-life care and preventing the suffering that leads to requests for assisted suicide. In California, the group delivered recommendations to the General Assembly’s Select Committee on Palliative Care. (1998 and 2001-2002)
Mike helped the Centers for Disease Control and Prevention (CDC) to design and implement a stakeholder and public engagement process aimed at assisting CDC’s Advisory Council on Immunization Practices (ACIP) to decide whether to add meningococcal vaccines to the infant immunization schedule. Stakeholders ranged from the American Academy of Pediatrics to the Heritage Foundation to the Association of State and Territorial Health Officials. (2011)